Profile cover photo
Profile photo
AntriaBio, Inc.
4 followers -
AntriaBio is a biopharmaceutical company focused on developing novel therapeutic products for the diabetes market.
AntriaBio is a biopharmaceutical company focused on developing novel therapeutic products for the diabetes market.

4 followers
About
AntriaBio, Inc.'s posts

Post has attachment

Post has attachment
The diaTribe team recently discussed the importance of diabetes education with the 2014 American Association of Diabetes Educators (AADE) President, Joan Bardsley. Click to read the eye-opening interview: http://bit.ly/1wDJFSg

Post has attachment

Post has attachment
The International Diabetes Federation estimated over 590 million people globally will be living with diabetes by 2035, many of whom may require basal insulin. If our lead product candidate, AB101, is approved, it could make significant inroads in the $10 billion basal insulin market and meaningfully improve the current standard of diabetes care. http://bit.ly/1AbQ74n

Post has attachment

Post has attachment
In addition to AB101, AntriaBio may use its formulation capabilities for a variety of opportunities across multiple indications. Visit our website to learn more about our pipeline. http://bit.ly/1rPwRXz

Post has attachment
What are some lifestyle changes you can implement to help control your diabetes? http://bit.ly/1uA9ePB

Post has attachment

Post has attachment
Using insulin can help control complications in both Type 1 and Type 2 diabetes. http://bit.ly/1uETcnG

Post has attachment
Read Nevan Elam's blog post, "Big Pharma Strategic Partnerships," and all of AntriaBio's blogs, available here: http://bit.ly/1sBBeXR
Wait while more posts are being loaded